Published in AJR Am J Roentgenol on December 01, 1993
Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax (2001) 2.74
Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax (2003) 2.54
Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax (1999) 1.17
Capsaicin induced cough in cryptogenic fibrosing alveolitis. Thorax (2000) 1.02
Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis (2002) 1.01
Pulmonary involvement in rheumatoid arthritis. Rheumatol Int (2004) 0.97
The clinical significance of HRCT in evaluation of patients with rheumatoid arthritis-associated interstitial lung disease: a report from China. Rheumatol Int (2010) 0.92
Lung involvement in systemic sclerosis. Presse Med (2010) 0.90
Diffuse lung disease: an approach to management. BMJ (1994) 0.89
Imaging lung disease in systemic sclerosis. Curr Rheumatol Rep (2010) 0.88
Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis. Clin Med Insights Circ Respir Pulm Med (2015) 0.84
Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis. Thorax (1998) 0.83
Severity classification for idiopathic pulmonary fibrosis by using fuzzy logic. Clinics (Sao Paulo) (2011) 0.83
In search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many? Thorax (1998) 0.80
Computer-aided quantification of interstitial lung disease from high resolution computed tomography images in systemic sclerosis: correlation with visual reader-based score and physiologic tests. Biomed Res Int (2015) 0.80
The promising role of lung ultrasound in systemic sclerosis. Clin Rheumatol (2012) 0.76
Review of cryptogenic fibrosing alveolitis, including current treatment guidelines. Postgrad Med J (2000) 0.75
Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax (2008) 4.78
Is lung cancer associated with asbestos exposure when there are no small opacities on the chest radiograph? Lancet (1995) 3.59
Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology (1996) 3.39
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (2000) 2.63
Accuracy of the typical computed tomographic appearances of fibrosing alveolitis. Thorax (1993) 2.33
Primary Pneumocystis carinii and cytomegalovirus infections. Lancet (1981) 2.23
Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology (2001) 2.20
A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1999) 2.08
Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax (2004) 1.96
BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J (2003) 1.81
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. Eur Respir J (2009) 1.75
Retained intrathoracic surgical swab: CT appearances. J Thorac Imaging (2000) 1.70
Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis. Am J Pathol (1997) 1.70
PET/CT in non-small cell lung cancer staging-promises and problems. Clin Radiol (2007) 1.68
Elevated levels of exhaled nitric oxide in bronchiectasis. Am J Respir Crit Care Med (1995) 1.67
Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J (2010) 1.65
UK Lung Screen (UKLS) nodule management protocol: modelling of a single screen randomised controlled trial of low-dose CT screening for lung cancer. Thorax (2011) 1.62
The source and role of RANTES in interstitial lung disease. Eur Respir J (1997) 1.62
Computed tomography of diffuse pulmonary haemorrhage with pathological correlation. Clin Radiol (1993) 1.55
Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. Chest (1996) 1.54
Unusual sclerosing haemangiomas and sclerosing haemangioma-like lesions, and the value of TTF-1 in making the diagnosis. Histopathology (2002) 1.53
Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax (1985) 1.52
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J (2009) 1.51
Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1994) 1.49
Challenges in pulmonary fibrosis: 8--The need for an international registry for idiopathic pulmonary fibrosis. Thorax (2008) 1.48
Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathol (1997) 1.47
Mannose-binding lectin promoter and structural gene variants in sarcoidosis. Eur J Clin Invest (2000) 1.46
Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests. Thorax (2000) 1.44
Clearance of inhaled technetium-99m-DTPA as a clinical index of pulmonary vascular disease in systemic sclerosis. Eur Respir J (1999) 1.44
Computed tomography signs of pulmonary hypertension: old and new observations. Clin Radiol (2009) 1.44
The value of negative needle biopsy in suspected operable lung cancer. Clin Radiol (1991) 1.41
Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. Clin Radiol (1994) 1.41
Expression of the neutrophil elastase gene during human bone marrow cell differentiation. J Exp Med (1989) 1.39
Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology (2004) 1.38
Considerations when introducing a new cardiac MDCT service. Avoiding the pitfalls. Clin Radiol (2008) 1.38
Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J (1997) 1.36
The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. J Am Coll Cardiol (2000) 1.34
Intrapleural streptokinase in the management of empyema. Thorax (1994) 1.34
Immunocompetent cells in bronchoalveolar lavage reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis. Am Rev Respir Dis (1985) 1.32
Reactive pulmonary lymphoid disorders. Histopathology (1995) 1.32
Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med (1997) 1.31
Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology (2000) 1.31
CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. AJR Am J Roentgenol (1995) 1.30
Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res (2000) 1.30
Clearance of inhaled 99mTc-DTPA predicts the clinical course of fibrosing alveolitis. Eur Respir J (1993) 1.29
HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax (2004) 1.29
The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis. Am Rev Respir Dis (1993) 1.28
Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease. Clin Radiol (1991) 1.27
Coronary artery imaging in grown up congenital heart disease: complementary role of magnetic resonance and x-ray coronary angiography. Circulation (2000) 1.26
High resolution computed tomography as a predictor of lung histology in systemic sclerosis. Thorax (1992) 1.23
Capsular distension and intracapsular pressure in subcapital fractures of the femur. J Bone Joint Surg Br (1988) 1.22
HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J Immunol (2001) 1.22
Bronchiectasis: functional significance of areas of decreased attenuation at expiratory CT. Radiology (1994) 1.21
Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. J Thorac Cardiovasc Surg (2003) 1.20
Accuracy of CT in the diagnosis of allergic bronchopulmonary aspergillosis in asthmatic patients. AJR Am J Roentgenol (1999) 1.19
Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax (2001) 1.18
Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax (1999) 1.17
Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J (2011) 1.17
Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro. Am J Respir Cell Mol Biol (1994) 1.16
Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies. Eur Respir J (1999) 1.15
Thin-section CT of the lungs: eye-tracking analysis of the visual approach to reading tiled and stacked display formats. Eur J Radiol (2006) 1.13
The density of HLA-DR antigen expression on alveolar macrophages is increased in pulmonary sarcoidosis. Clin Exp Immunol (1986) 1.11
Role of bronchoalveolar lavage in the evaluation of interstitial pneumonitis in recipients of bone marrow transplants. Thorax (1987) 1.10
Pulmonary perfusion in supine and prone positions: an electron-beam computed tomography study. J Appl Physiol (1985) (2001) 1.09
Acute interstitial pneumonia. Eur Respir J (2000) 1.09
Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. Eur Respir J (2009) 1.08
Bronchiolitis obliterans: high resolution CT findings and correlation with pulmonary function tests. Clin Radiol (1993) 1.08
Fibrosing alveolitis in systemic sclerosis: indices of lung function in relation to extent of disease on computed tomography. Arthritis Rheum (1997) 1.08
The value of classifying interstitial pneumonitis in childhood according to defined histological patterns. Histopathology (1998) 1.07
Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun (2003) 1.07
8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med (1998) 1.07
Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP. Genes Immun (2001) 1.07
High-resolution computed tomography of drug-induced lung disease. Clin Radiol (1992) 1.05
Follicular bronchiolitis: thin-section CT and histologic findings. Radiology (1999) 1.05
Comparative appearances of non-tuberculous mycobacteria species: a CT study. Eur Radiol (2002) 1.03
Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance. Am J Respir Crit Care Med (1994) 1.02